Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Cash from Operations (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Cash from Operations for 14 consecutive years, with 239000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations fell 134.0% to 239000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2794000.0 through Dec 2025, down 1586.17% year-over-year, with the annual reading at 2794000.0 for FY2025, 1586.17% down from the prior year.
  • Cash from Operations hit 239000.0 in Q4 2025 for STRATA Skin Sciences, down from 64000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 1371000.0 in Q4 2023 to a low of 2020000.0 in Q3 2023.
  • Historically, Cash from Operations has averaged 127050.0 across 5 years, with a median of 60000.0 in 2022.
  • Biggest five-year swings in Cash from Operations: skyrocketed 1791.07% in 2023 and later plummeted 428.43% in 2025.
  • Year by year, Cash from Operations stood at 669000.0 in 2021, then plummeted by 73.24% to 179000.0 in 2022, then skyrocketed by 665.92% to 1371000.0 in 2023, then plummeted by 48.72% to 703000.0 in 2024, then tumbled by 134.0% to 239000.0 in 2025.
  • Business Quant data shows Cash from Operations for SSKN at 239000.0 in Q4 2025, 64000.0 in Q3 2025, and 1941000.0 in Q2 2025.